PRUNE1
protein-codingprune exopolyphosphatase 1
Gene summary
This gene encodes a member of the DHH protein superfamily of phosphoesterases. This protein has been found to function as both a nucleotide phosphodiesterase and an exopolyphosphatase. This protein is believed to stimulate cancer progression and metastases through the induction of cell motility. A pseuodgene has been identified on chromosome 13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
- PRUNE
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0060490
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0060490
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0060490
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0060490
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRUNE1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021222.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 33 | 1 | 35 | ||
| missense | 3 | 5 | 36 | 8 | 4 | 56 |
| nonsense | 4 | 3 | 3 | 10 | ||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 3 | 8 | |||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | 6 | ||
| Total | 13 | 14 | 43 | 41 | 5 | 116 |
Highest pathogenic variant AF is 0.000025405276
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_067045.1 | 8 | MANE Select | |
| Ensembl | ENSP00000271620.3 | 8 | MANE Select | |
| RefSeq | NP_001290158.1 | 4 | Standard | |
| RefSeq | NP_001290171.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Purine metabolism - Homo sapiens (human)
Biological Process
- polyphosphate catabolic process
- dephosphorylation
- regulation of microtubule polymerization
- regulation of neurogenesis
Molecular Function
- exopolyphosphatase activity
- inorganic diphosphatase activity
- protein binding
- tubulin binding
- phosphatase activity
Cellular Component
- nucleus
- cytoplasm
- cytosol
- focal adhesion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000271620
- Coding exons
- 8
- Length
- 27294
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 25
- Defined
- 125747
- p
- 0.0000994
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.11 | 193 | 242 | 0.799 | 0.0000122 | 2933 |
| Missense (PolyPhen) | 54 | 82.829 | 0.65195 | 1009 | ||
| Synonymous | 1.34 | 82 | 99.0 | 0.828 | 0.00000500 | 935 |
| Loss of Function | 2.68 | 7 | 19.9 | 0.352 | 0.00000113 | 220 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Phosphodiesterase (PDE) that has higher activity toward cAMP than cGMP, as substrate. Plays a role in cell proliferation, migration and differentiation, and acts as a negative regulator of NME1. Plays a role in the regulation of neurogenesis (PubMed:28334956). Involved in the regulation of microtubule polymerization (PubMed:28334956). {ECO:0000269|PubMed:10602478, ECO:0000269|PubMed:11687967, ECO:0000269|PubMed:14998490, ECO:0000269|PubMed:16428445, ECO:0000269|PubMed:17906697, ECO:0000269|PubMed:28334956}.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- RVIS EVS
- 0.71
- RVIS percentile EVS
- 85.63
Essentials
- Essential (gene trap)
- N